These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20649633)

  • 21. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Tan Q; Jensen T; Kruse TA; Beck-Nielsen H; Højlund K
    PLoS One; 2008 Jun; 3(6):e2466. PubMed ID: 18560589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.
    Gaebler JA; Soto-Campos G; Alperin P; Cohen M; Blickensderfer A; Wintle M; Maggs D; Hoogwerf B; Han J; Pencek R; Peskin B
    Vasc Health Risk Manag; 2012; 8():255-64. PubMed ID: 22566747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiazolidinediones improve beta-cell function in type 2 diabetic patients.
    Gastaldelli A; Ferrannini E; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E871-83. PubMed ID: 17106061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
    de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
    Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus.
    Bajaj M; Baig R; Suraamornkul S; Hardies LJ; Coletta DK; Cline GW; Monroy A; Koul S; Sriwijitkamol A; Musi N; Shulman GI; DeFronzo RA
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1916-23. PubMed ID: 20157197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens.
    Charbonnel B; Roden M; Urquhart R; Mariz S; Johns D; Mihm M; Widel M; Tan M
    Diabetologia; 2005 Mar; 48(3):553-60. PubMed ID: 15739120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content.
    Balasubramanian R; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R
    Diabet Med; 2010 Feb; 27(2):150-6. PubMed ID: 20546257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes.
    Wessels B; Ciapaite J; van den Broek NM; Houten SM; Nicolay K; Prompers JJ
    Diabetes Obes Metab; 2015 Jan; 17(1):52-60. PubMed ID: 25200673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes.
    Meng Q; Qi X; Fu Y; Chen Q; Cheng P; Yu X; Sun X; Wu J; Li W; Zhang Q; Li Y; Wang A; Bian H
    J Ethnopharmacol; 2020 Feb; 248():112326. PubMed ID: 31639486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
    Joya-Galeana J; Fernandez M; Cervera A; Reyna S; Ghosh S; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Diabetes Metab Res Rev; 2011 May; 27(4):373-82. PubMed ID: 21309063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials with thiazolidinediones in subjects with Type 2 diabetes--is pioglitazone any different from rosiglitazone?
    Doggrell SA
    Expert Opin Pharmacother; 2008 Feb; 9(3):405-20. PubMed ID: 18220491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pioglitazone hydrochloride monotherapy or in combination with sulfonylurea therapy improves glycemia control in patients with type 2 diabetes].
    Yu Y; Li Y; Fan J; Wang Y; Yu H; Wang C; Liao Z; Gao H; Zhao W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):117-20. PubMed ID: 15600200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.
    Bravard A; Lefai E; Meugnier E; Pesenti S; Disse E; Vouillarmet J; Peretti N; Rabasa-Lhoret R; Laville M; Vidal H; Rieusset J
    Diabetes; 2011 Jan; 60(1):258-68. PubMed ID: 20943749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.
    Larsen S; Stride N; Hey-Mogensen M; Hansen CN; Andersen JL; Madsbad S; Worm D; Helge JW; Dela F
    Diabetologia; 2011 Jun; 54(6):1427-36. PubMed ID: 21424396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
    Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
    J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity.
    Mendham AE; Goedecke JH; Zeng Y; Larsen S; George C; Hauksson J; Fortuin-de Smidt MC; Chibalin AV; Olsson T; Chorell E
    Diabetologia; 2021 Jul; 64(7):1642-1659. PubMed ID: 33770195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice.
    Kawashima S; Matsuoka TA; Kaneto H; Tochino Y; Kato K; Yamamoto K; Yamamoto T; Matsuhisa M; Shimomura I
    Biochem Biophys Res Commun; 2011 Jan; 404(1):534-40. PubMed ID: 21144823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.